Answers are grounded in this paper and cite their sources.
Purpose: We conjectured that obstructive sleep apnea (OSA) is associated with an increased risk of ventricular arrhythmias freely of other risk issues and that the harshness of OSA is directly allied with the extent of this risk.In this curent study, we assessed the effects of clonazepam and zolpidem in OSA in patients with advanced chronic kidney disease (CKD) and mild left ventricular (LV) dysfunction.Methods: This transversal study involved 30 patients with CKD stage 4, fifteen of them using clonazepam 2 mg and the other 15 patients using zolpidem 10mg before to sleep due to a disturbance to sleep.Results: During the polysomnography, the group using clonazepam 2 mg showed a higher apnea/hypopnea index events (47.3 ± 6.5 events/hour) in comparison with the group using zolpidem 10 mg (10.4 ± 3.3 events/hour), P<0.0001.The 24-hour Holter monitoring presented a mean number of non-sustained ventricular tachycardia (NSVT) during the day, night, and whole period, respectively of 3.1 ± 1.9, 18.2 ± 2.1, and 10.7 ± 2.0 for the subjects using 2 mg of clonazepam, as well as, 9.4 ± 2.5, 3.3 ± 1.5, and 6.3 ± 1.8 for the individuals using zolpidem 10 mg (all the comparisons between groups into the same period were significant, P<0.0001 for all of them). Conclusion:There were the highest number of AHI events in patients using clonazepam 2 mg than in those using zolpidem 10 mg, as well as, a major incidence of NSVT in the first group compared to the second one, during the whole period recorded by the 24-hour Holter monitoring.
No takes yet. Share an insight, caveat, or question.
Kiuchi et al. (2017) studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: